journal article·2013-10

In vivo tumor targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models

João Conde, Furong Tian, Yulán Hernández, Chenchen Bao, Daxiang Cui, Klaus-Peter Janssen, M. Ricardo Ibarra, Pedro V. Baptista, Tobias Stoeger, Jesús M. de la Fuente

Biomaterials· Volume 34· Issue 31
Publisher page

Abstract

Up to now, functionalized gold nanoparticles have been optimized as an effective intracellular in vitro delivery vehicle for siRNAs to interfere with the expression of specific genes by selective targeting, and provide protection against nucleases. Few examples however of suchlike in vivo applications have been described so far. In this study, we report the use of siRNA/RGD gold nanoparticles capable of targeting tumor cells in a lung cancer syngeneic orthotopic murine model. Therapeutic RGD-nanoparticle treatment resulted in successful targeting evident from significant c-myc oncogene down-regulation followed by tumor growth inhibition and prolonged survival of lung tumor bearing mice, possibly via αvβ3 integrin interaction. Our results suggest that RGD gold nanoparticles-mediated delivery of siRNA by intratracheal instillation in mice leads to successful suppression of tumor cell proliferation and respective tumor size reduction. These results reiterate the capability of functionalized gold nanoparticles for targeted delivery of siRNA to cancer cells towards effective silencing of the specific target oncogene. What is more, we demonstrate that the gold-nanoconjugates trigger a complex inflammatory and immune response that might promote the therapeutic effect of the RNAi to reduce tumor size with low doses of siRNA.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (34)

Show source-provided references
1. Potent and specific genetic interference by double-stranded RNA in caenorhabditis elegans10.1038/35888 ↗
2. Small RNA: can RNA interference be exploited for therapy?10.1016/S0140-6736(03)14637-5 ↗
3. Dual gene targeted multimeric siRNA for combinatorial gene silencing10.1016/j.biomaterials.2010.11.062 ↗
4. The packaging of siRNA within the mesoporous structure of silica nanoparticles10.1016/j.biomaterials.2011.08.068 ↗
5. Endosomal escape and siRNA delivery with cationic shell crosslinked knedel-like nanoparticles with tunable buffering capacities10.1016/j.biomaterials.2012.07.054 ↗
6. Composite nanoparticles take aim at cancer10.1021/nn800716j ↗
7. Nanocarriers as an emerging platform for cancer therapy10.1038/nnano.2007.387 ↗
8. Theranostic nanomedicines10.1021/ar200019c ↗
9. Gold nanoparticles in delivery applications10.1016/j.addr.2008.03.016 ↗
10. Noble metal nanoparticles applications in cancer
11. Effective gene silencing by multilayered siRNA-coated gold nanoparticles10.1002/smll.201001314 ↗
12. Dendronized gold nanoparticles for siRNA delivery10.1002/smll.201201141 ↗
13. Gene regulation with polyvalent siRNA-nanoparticle conjugates10.1021/ja808719p ↗
14. Controlled synthesis of PEI-coated gold nanoparticles using reductive catechol chemistry for siRNA delivery10.1016/j.jconrel.2010.09.009 ↗
15. Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery10.1002/smll.200901513 ↗
16. Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery10.1021/nl9009793 ↗
17. Amine-functionalized gold nanoparticles as non-cytotoxic and efficient intracellular siRNA delivery carriers10.1016/j.ijpharm.2008.07.027 ↗
18. Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte10.1021/nn101638u ↗
19. Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing10.1021/nn3030223 ↗
20. RGD peptide-conjugated poly(dimethylsiloxane) promotes adhesion, proliferation, and collagen secretion of human fibroblasts10.1002/jbm.a.30847 ↗
21. Multimodality tumor imaging targeting integrin alphavbeta310.2144/000112091 ↗
22. Comparison of particle-exposure triggered pulmonary and systemic inflammation in mice fed with three different diets10.1186/1743-8977-8-30 ↗
23. Mannose 6-phosphate/insulin-like growth factor 2 receptor limits cell invasion by controlling alphaVbeta3 integrin expression and proteolytic processing of urokinase-type plasminogen activator receptor10.1091/mbc.e08-06-0569 ↗
24. Cell surface properties of high- and low-metastatic cell lines selected from a spontaneous mouse lung carcinoma10.1002/ijc.2910320619 ↗
25. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution10.1021/mp800032f ↗
26. Cytotoxicity of nanoparticles10.1002/smll.200700595 ↗
27. Requirement of vascular integrin αvβ3 for angiogenesis10.1126/science.7512751 ↗
28. Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway10.1038/sj.gt.3300783 ↗
29. Cancer statistics, 2012
30. Modelling Myc inhibition as a cancer therapy10.1038/nature07260 ↗
31. Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads10.1021/ja9071282 ↗
32. Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin10.1021/ja908117a ↗
33. Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model10.1021/mp060132k ↗
34. Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis10.1371/journal.pone.0028133 ↗